Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1)

This study has been terminated.
Information provided by (Responsible Party):
Tesaro, Inc. Identifier:
First received: April 22, 2010
Last updated: May 4, 2016
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)